Literature DB >> 23034372

Magnesium sulphate in management of severe pre-eclampsia and eclampsia.

G Dhakal1, M Subedi, K Paudel.   

Abstract

BACKGROUND: Pre-eclampsia and eclampsia (PE/E) are the second leading cause of maternal mortality in Nepal accounting for 21% of all maternal deaths and 30% of all facility based maternal deaths. For treatment of severe pre-eclampsia and eclampsia (SPE/E), WHO has identified magnesium sulphate (MgSO4) as the most effective and low cost medication. The objective of the study was to explore current situation of SPE/E management using MgSO4 in 10 health facilities of Mid Western Development Region.
METHODS: Descriptive and single group pre-test, post test study design was used for the study. Data were collected by reviewing records, taking interviews and through observation. Knowledge and skills of service provider was assessed and scored (0-100%) before and after the educational intervention.
RESULTS: One year records indicate that 0.5% SPE/E cases were found in Dang Sub Regional Hospital and Pyuthan District Hospital; 0.4% in Bheri Zonal Hospital; 0.9% in Mehelkuna PHCC and 0.5% in Rajapur PHCC. In most of the hospitals, these cases were managed with MgSO4. During pre-testing none of the health facility was able to get standard score (80%) but in post test, 50% health facilities were able to get 80% or higher score.
CONCLUSIONS: Establishing national standard and providing one-time training is not sufficient, it requires refresher onsite training for propermanagement of SPE/E on time to improve maternal and neonatal health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23034372

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  4 in total

1.  Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan.

Authors:  Young Mi Kim; Nasratullah Ansari; Adrienne Kols; Hannah Tappis; Sheena Currie; Partamin Zainullah; Patricia Bailey; Jos van Roosmalen; Jelle Stekelenburg
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-12       Impact factor: 3.007

2.  Prioritizing investments in innovations to protect women from the leading causes of maternal death.

Authors:  Tara M Herrick; Claudia M Harner-Jay; Alice M Levisay; Patricia S Coffey; Michael J Free; Paul D LaBarre
Journal:  BMC Pregnancy Childbirth       Date:  2014-01-09       Impact factor: 3.007

3.  Community health worker knowledge and management of pre-eclampsia in southern Mozambique.

Authors:  Helena Boene; Marianne Vidler; Orvalho Augusto; Mohsin Sidat; Eusébio Macete; Clara Menéndez; Diane Sawchuck; Rahat Qureshi; Peter von Dadelszen; Khátia Munguambe; Esperança Sevene
Journal:  Reprod Health       Date:  2016-09-30       Impact factor: 3.223

4.  Optimizing treatment for the prevention of pre-eclampsia/eclampsia in Nepal: is calcium supplementation during pregnancy cost-effective?

Authors:  Isabelle Feldhaus; Amnesty E LeFevre; Chandra Rai; Jona Bhattarai; Deirdre Russo; Barbara Rawlins; Pushpa Chaudhary; Kusum Thapa
Journal:  Cost Eff Resour Alloc       Date:  2016-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.